SCHEMBL1388946

SCHEMBL1388946

c1ccc2c(c1)CCc1c(CN3CCN(c4ccc5ccccc5n4)CC3)n[nH]c1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.49
HTR3A P46098 6/20 0.47
HTR3E A5X5Y0 2/20 0.46
KDM4E B2RXH2 2/20 0.46
HTR3B O95264 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 2/20 0.46
HTR3D Q70Z44 2/20 0.46
HTR3C Q8WXA8 2/20 0.46
THPO P40225 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
HTR1A P08908 6/20 0.46
DRD4 P21917 1/20 0.44
HTR7 P34969 2/20 0.43
USP2 O75604 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR2C P28335 1/20 0.43
MAPK1 P28482 1/20 0.43
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1388902 0.82 HTR3A (0.47) HTR3ADRD4MAPK1NPC1RAB9A
SCHEMBL1388980 0.80 DRD4 (0.48) ALDH1A1HTR1ADRD4HTR7HTR2C
SCHEMBL1389022 0.79 KDR (0.52) HTR1ADRD4HTR2CDRD2
SCHEMBL1389143 0.75 CD44 (0.49) KDM4EALDH1A1HTR1ADRD4HTR7
SCHEMBL1388900 0.75 DRD3 (0.49) HRH4DRD4USP2HTTHSD17B10
SCHEMBL8631184 0.74 HRH3 (0.56) HRH3HTR3AHTR3EKDM4EHTR3B
SCHEMBL1388929 0.74 PARP1 (0.49) KDM4EALDH1A1DRD4DRD2
SCHEMBL8921653 0.71 HRH3 (0.52) HRH3HTR3AHTR3EKDM4EHTR3B
SCHEMBL1388880 0.71 DRD4 (0.45) KDM4EALDH1A1HTR1ADRD4CYP3A4
SCHEMBL6231596 0.70 HRH3 (0.68) HRH3HTR3AHTR3EKDM4EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0717733-B1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME (GB) 1997-12-03 EP claimed
EP-0664807-B1 QUINOXALINEDIONE DERIVATIVES AS EAA ANTAGONISTS WARNER LAMBERT CO (US) 1997-09-10 EP claimed
JP-H09502199-A 1997-03-04 JP claimed
EP-0717733-A1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME LTD. (GB) 1996-06-26 EP claimed
WO-1995007262-A1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1995-03-16 WO claimed
EP-0717733-B1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME (GB) 1997-12-03 EP disclosed
US-5686480-A Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands MERCK, SHARP & DOHME, LTD. (GB) 1997-11-11 US disclosed
EP-0717733-A1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME LTD. (GB) 1996-06-26 EP disclosed
WO-1995007262-A1 FUSED TRICYCLIC HETEROAROMATIC DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1995-03-16 WO disclosed